N-acetylcysteine, xCT and suppression of Maxi-chloride channel activity in human placenta

Placenta. 2021 Jul:110:46-55. doi: 10.1016/j.placenta.2021.05.009. Epub 2021 Jun 5.

Abstract

Introduction: Placental oxidative stress features in pregnancy pathologies but in clinical trials antioxidant supplementation has not improved outcomes. N-acetylcysteine (NAC) stimulates glutathione production and is proposed as a therapeutic agent in pregnancy. However, key elements of N-acetylcysteine biology, including its cellular uptake mechanism, remains unclear. This study explores how the cystine/glutamate transporter xCT may mediate N-acetylcysteine uptake and how N-acetylcysteine alters placental redox status.

Methods: The involvement of xCT in NAC uptake by the human placenta was studied in perfused placenta and Xenopus oocytes. The effect of short-term N-acetylcysteine exposure on the placental villous proteome was determined using LC-MS. The effect of N-acetylcysteine on Maxi-chloride channel activity was investigated in perfused placenta, villous fragments and cell culture.

Results: Maternoplacental N-acetylcysteine administration stimulated intracellular glutamate efflux suggesting a role of the exchange transporter xCT, which was localised to the microvillous membrane of the placental syncytiotrophoblast. Placental exposure to a bolus of N-acetylcysteine inhibited subsequent activation of the redox sensitive Maxi-chloride channel independently of glutathione synthesis. Stable isotope quantitative proteomics of placental villi treated with N-acetylcysteine demonstrated changes in pathways associated with oxidative stress, apoptosis and the acute phase response.

Discussion: This study suggests that xCT mediates N-acetylcysteine uptake into the placenta and that N-acetylcysteine treatment of placental tissue alters the placental proteome while regulating the redox sensitive Maxi-chloride channel. Interestingly N-acetylcysteine had antioxidant effects independent of the glutathione pathway. Effective placental antioxidant therapy in pregnancy may require maintaining the balance between normalising redox status without inhibiting physiological redox signalling.

Keywords: Antioxidant; Membrane transport; Redox.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / metabolism
  • Acetylcysteine / pharmacology*
  • Amino Acid Transport System y+ / genetics*
  • Amino Acid Transport System y+ / metabolism
  • Animals
  • Chloride Channels / antagonists & inhibitors*
  • Chloride Channels / metabolism
  • Chorionic Villi / drug effects
  • Chorionic Villi / metabolism
  • Female
  • Gene Expression / drug effects
  • Glutamic Acid / drug effects
  • Glutamic Acid / metabolism
  • HEK293 Cells
  • Humans
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / drug effects
  • Oxidative Stress / genetics
  • Placenta* / drug effects
  • Placenta* / metabolism
  • Pregnancy
  • Proteome / drug effects
  • Proteome / metabolism
  • Xenopus laevis

Substances

  • Amino Acid Transport System y+
  • Chloride Channels
  • Proteome
  • SLC7A11 protein, human
  • Glutamic Acid
  • Acetylcysteine